Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04398537 · ClinicalTrials.gov registry record · NA
The Role of Pre-deployment Retraction in Decreasing Biopsy Clip Migration During Stereotactic Breast Biopsies
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 245
- Enrollment target
NCT04398537 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 245 participants.
The verdict
NCT04398537, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 245 participants
- Enrollment target
Study Summary
This will be a single-center prospective randomized control trial that is Institutional Review Board (IRB) approved. The study plans to enroll 250 female patients presenting to the University of Alabama at Birmingham (UAB) for stereotactic biopsy. This study is a prospective and will target approximately 250 patients. This will be a HIPPA-compliant randomized control trial planned on spanning approximately six months' time. Patients will be entered into the study only based on their already scheduled stereotactic biopsy procedure. Patients will be informed of the study and they will be offered the opportunity to participate or not participate in the study. Their participation is completely voluntary. This study will not involve any intervention that is not already a part of standard care. Patients will be randomized to two groups, one group that will undergo clip placement with approximately with a 5 mm retraction of the biopsy clip post-placement and one that will involve no retraction prior to deployment.
Interventions
- DEVICE 5mm retraction of clip deployment apparatus.
- DEVICE No retraction of clip deployment apparatus.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 245 participants |
| Start Date | 2020-08-03 |
| Est. Completion | 2023-07-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04398537
The ClinicalTrials.gov registry entry for NCT04398537 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 245 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 5mm retraction of clip deployment apparatus. is the first listed.
NCT04398537 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04398537 about?
NCT04398537 is a clinical study titled "The Role of Pre-deployment Retraction in Decreasing Biopsy Clip Migration During Stereotactic Breast Biopsies". This will be a single-center prospective randomized control trial that is Institutional Review Board (IRB) approved. The study plans to enroll 250 female patients presenting to the University of Alabama at Birmingham (UAB) for stereotactic biopsy. This study is a prospective and will target approxim...
What is the current status of trial NCT04398537?
This trial is currently completed. It is a NA study. The enrollment target is 245 participants. The study started on 2020-08-03. Estimated completion is 2023-07-26.
What interventions are being tested in trial NCT04398537?
The interventions under investigation include: 5mm retraction of clip deployment apparatus. (DEVICE), No retraction of clip deployment apparatus. (DEVICE).
Who is sponsoring clinical trial NCT04398537?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.